AntiCoagulation Tracking InterVention and Evaluation
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- 950
Summary
- Conditions
- Anticoagulation
- Atrial Fibrillation
- Atrial Flutter
- Deep Vein Thrombosis
- Hypercoagulability
- Pulmonary Embolus/Emboli
- Stroke
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 99 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04059965
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Urmimala Sarkar, MD, MPH University of California, San Francisco